The era of one-size-fits-all cancer treatment is evolving. The integration of molecular biomarkers is revolutionizing oncology, paving the way for stratified and personalized therapeutic strategies that deliver more effective, targeted care for patients.
Our webinar, "Delivering Personalized Oncology for Patients: Integrating Molecular Signatures in Clinical Practice," features experts Joe Shaw (North West Genomic Laboratory Hub) and Yannick Le Bris (Nantes University Hospital). They will explore how molecular signatures are personalizing cancer care, from guiding principles to direct clinical application.
In this essential webinar, you will discover:
- Targeted Ovarian Cancer Therapy: Learn how homologous recombination deficiency (HRD) testing is used to guide PARP inhibitor therapy, illustrated with a real-world clinical case study.
- Strategic CLL Management: Understand how IGVH mutation status is used to direct treatment strategy in chronic lymphocytic leukemia (CLL), improving patient outcomes.
- Practical Application: Gain actionable insights into applying these powerful molecular tools to deliver personalized oncology in your own clinical practice.
Meet the Speakers:
- Joe Shaw: Clinical Scientist at the North West Genomic Laboratory Hub, specializing in the validation of new genetic tests. His current work focuses on genomic instability testing in ovarian cancer and he is a passionate advocate for open-source data science in genomics.
- Yannick Le Bris: Head of the Molecular Hematology Laboratory at Nantes University Hospital and affiliated with the European MCL Network. His research is centered on developing new molecular biomarkers for precision medicine in hematology.
Join these leading experts to explore how molecular signatures are transforming the future of cancer treatment.
